CJC-1295 + Ipamorelin: The Gold Standard Growth Hormone Stack

The CJC-1295 ipamorelin stack has become the default recommendation in peptide research for good reason: it produces 2-5x more growth hormone release than either peptide alone, with a side effect profile that makes HGH injections look primitive by comparison. If exogenous GH is a sledgehammer, this combination is a precision instrument — amplifying your body's own pulsatile GH secretion pattern rather than overriding it.

This is the "peanut butter and jelly" of GH peptides. One provides the signal. The other amplifies the response. Together, they create synergy that single-compound protocols cannot match.

Here's why, how, and exactly what to expect week by week.

The Mechanism: Why CJC-1295 + Ipamorelin Work Together

Understanding the GH peptide stack requires understanding the two separate signals that trigger growth hormone release from the pituitary gland.

Signal 1: GHRH (Growth Hormone Releasing Hormone)

Your hypothalamus releases GHRH in pulses throughout the day, telling the pituitary to produce and release GH. This is the "permission signal."

CJC-1295 is a synthetic analog of GHRH — a 29-amino acid peptide modified for extended half-life. It mimics your body's natural release signal but with greater potency and duration [1].

Key properties:

• Stimulates GH synthesis AND release from somatotroph cells
• 30-minute half-life (no DAC version) or 8+ day half-life (with DAC)
• Maintains the natural pulsatile pattern of GH release
• Does not cause GH "bleed" — releases in discrete pulses
• Amplifies existing GHRH pulses rather than creating continuous elevation

Signal 2: GHRP (Growth Hormone Releasing Peptide) / Ghrelin Mimetic

Separate from GHRH, the ghrelin receptor system provides an amplifying signal. When ghrelin binds its receptor on pituitary somatotrophs, it potentiates the GH release triggered by GHRH.

Ipamorelin is a selective ghrelin receptor agonist (GHS-R1a) — the cleanest GHRP available [2]. It:

• Amplifies GH release when GHRH signal is present
• Highly selective: stimulates GH without significantly raising cortisol, prolactin, or ACTH [3]
• 2-hour active window
• Dose-dependent GH release up to saturation point
• Does not desensitize with repeated use (unlike GHRP-6 or hexarelin)

The Synergy: 2-5x Amplification

When GHRH and GHRP signals arrive at the pituitary simultaneously, GH release isn't additive — it's multiplicative [4].

Research by Bowers et al. demonstrated that combining a GHRH analog with a GHRP produced GH responses 2-5x greater than the sum of either peptide alone [5]. The mechanism: GHRH opens the calcium channel on somatotroph cells, and the ghrelin signal amplifies calcium influx through a separate pathway. Both signals converging creates a synergistic cascade.

Practical translation: 100mcg of CJC-1295 alone might produce a GH pulse of 8-12 ng/mL. 100mcg of Ipamorelin alone might produce 6-10 ng/mL. Combined? 25-45 ng/mL — comparable to pharmacological GH doses but achieved through your own pituitary [6].

CJC-1295 No DAC vs. With DAC: Which Version?

This decision significantly impacts your protocol design.

CJC-1295 (No DAC) — Also Called "Mod GRF 1-29"

• Half-life: ~30 minutes
• Produces discrete GH pulses (mimics natural physiology)
• Must be dosed 2-3x daily for full benefit
• Pairs perfectly with Ipamorelin (same dosing schedule)
• Recommended for most researchers — preserves pulsatile GH pattern

CJC-1295 with DAC (Drug Affinity Complex)

• Half-life: 8+ days (binds albumin in blood)
• Produces sustained GH elevation rather than discrete pulses
• Dosed 1-2x per week
• Creates a "GH bleed" — continuously elevated baseline
• Higher risk of side effects (water retention, numbness, carpal tunnel)
• May desensitize pituitary over time due to constant stimulation
• Better for convenience, worse for physiology

Recommendation: CJC-1295 no DAC + Ipamorelin for optimal results with minimal side effects. The DAC version is appropriate for researchers who cannot maintain 2-3x daily dosing.

[Internal Link: /cjc-1295-no-dac/] [Internal Link: /cjc-1295-dac/] [Internal Link: /ipamorelin/]

The Gold Standard Protocol: Dosing

Standard Anti-Aging / Fat Loss / Recovery Protocol

Optimal Timing Protocol (3x/day)

1. Morning dose (upon waking, fasted): 100mcg CJC-1295 + 100mcg Ipamorelin
2. Afternoon dose (pre-workout or mid-afternoon, 3+ hours after last meal): 100mcg each
3. Evening dose (before bed, 2+ hours after dinner): 100mcg each — this is the most important dose

The evening dose is critical because it synergizes with your body's natural nocturnal GH surge. Sleep-onset GH release is the largest pulse of the day, and stacking peptides with this window produces the strongest response [7].

Why Fasted Administration Matters

Elevated blood glucose and insulin blunt GH release. Fat and carbohydrates consumed within 30-60 minutes of injection will reduce peptide efficacy by 30-50% [8]. Rules:

• No food 30 minutes before injection
• No food 30 minutes after injection
• Water, black coffee, and zero-calorie beverages are fine
• A small amount of protein (<10g) has minimal impact

Accelerated / Bodybuilding Protocol

For researchers prioritizing maximum GH output:

Important: Increasing Ipamorelin above 300mcg per dose does not produce proportionally more GH. The ghrelin receptor saturates, and excess peptide is wasted. Adding a third daily dose is more effective than increasing single-dose amounts [9].

Combining with DAC Version (Weekly Protocol)

For those using CJC-1295 with DAC:

• CJC-1295 DAC: 2mg once per week (subcutaneous)
• Ipamorelin: 100-200mcg 2-3x daily (to create GH pulses on top of the DAC baseline)

This hybrid approach provides continuous baseline elevation from DAC plus acute pulses from Ipamorelin. Some researchers prefer this for simplicity.

Benefits Timeline: What to Expect Week by Week

The CJC-1295 ipamorelin combination produces progressive benefits. Don't expect transformation overnight — this is optimization, not pharmacological override.

Week 1-2: Sleep and Recovery

• Sleep quality improvement: Deeper sleep onset, more vivid dreams, waking feeling more rested [10]
• Faster workout recovery: Reduced DOMS, less lingering fatigue
• Mild water retention: 1-3 lbs of water weight (this stabilizes)
• Increased appetite: Ipamorelin's ghrelin receptor activity mildly stimulates hunger

Week 3-4: Skin, Energy, Recovery Acceleration

• Skin quality: Improved hydration, reduced fine lines (GH stimulates collagen synthesis)
• Sustained energy: Less afternoon energy crashes
• Workout capacity: Ability to train more frequently without overreaching
• Joint comfort: GH-mediated improvements in synovial fluid quality

Week 4-8: Body Composition Shift

• Fat loss: Particularly visceral and stubborn subcutaneous fat (GH preferentially mobilizes abdominal fat) [11]
• Lean mass preservation or gain: Even in a caloric deficit, lean tissue is spared
• Hair and nail growth: Faster, thicker growth
• Recovery from injuries: Lingering nagging injuries begin resolving

Week 8-12+: Full Anti-Aging Effects

• Measurable body composition change: 5-10% reduction in body fat with consistent training
• Lean mass gains: 2-4 lbs of lean tissue (not water) over 12 weeks
• Skin tightening: Noticeable improvement in skin elasticity
• Cognitive clarity: Some researchers report improved focus and mental sharpness
• IGF-1 levels: Lab work typically shows 20-40% elevation in IGF-1 [12]

Who Is This Stack For?

Ideal Candidates

Anti-aging (35+ year olds): GH production declines approximately 14% per decade after age 30 [13]. The CJC-1295 + Ipamorelin stack restores youthful GH pulsatility without supraphysiological levels. This is hormone optimization, not bodybuilding abuse.

Fat loss plateau breakers: If diet and training are dialed but body composition won't budge, GH peptides mobilize the stubborn fat deposits that resist caloric deficit alone. Particularly effective for visceral fat.

Recovery-focused athletes: Canadian athletes dealing with long competitive seasons (hockey, MMA, CrossFit) benefit from accelerated inter-session recovery without the suppressive effects of anabolic compounds.

Post-cycle recovery: After anabolic steroid cycles, natural GH production may be suboptimal. The CJC-1295 + Ipamorelin stack supports recovery without further HPTA suppression.

Who Should Consider Alternatives

• Those wanting rapid, dramatic muscle gain: Actual HGH at bodybuilding doses (4-8 IU/day) produces faster results but with proportionally more side effects and cost ($500-2,000/month)
• Those with active cancer: GH and IGF-1 elevation is contraindicated
• Diabetics or pre-diabetics: GH peptides elevate blood glucose; monitoring required
• Those unwilling to inject 2-3x daily: Consider MK-677 (oral) as an alternative

Side Effects and Management

The growth hormone releasing stack has a favorable safety profile compared to exogenous HGH, but side effects exist:

Common (Expected, Manageable)

Uncommon (Monitor)

Rare (Discontinue and Assess)

• Carpal tunnel symptoms (persistent): Discontinue, symptoms resolve within 2 weeks
• Significant edema: Reduce dose by 50%, reassess after 1 week
• Joint pain (not stiffness): Rule out other causes; not typical of this stack

CJC-1295 Ipamorelin Stack vs. Exogenous HGH: Side Effect Comparison

Comparison: CJC-1295 + Ipamorelin vs. Other GH Secretagogues

Vs. MK-677 (Ibutamoren)

Vs. GHRP-6 + CJC-1295

GHRP-6 is a less selective ghrelin mimetic than Ipamorelin:

• Causes intense hunger (useful for bulking, problematic for cutting)
• Raises cortisol and prolactin more than Ipamorelin [14]
• Slightly higher GH release ceiling at maximum doses
• More side effects overall

Verdict: Ipamorelin is preferred for most applications. GHRP-6 only for those specifically wanting appetite stimulation.

Vs. Tesamorelin

Tesamorelin is an FDA-approved GHRH analog (for HIV lipodystrophy):

• More potent GHRH signal than CJC-1295
• Specifically targets visceral fat
• Expensive (pharmaceutical pricing)
• No clear advantage when combined with a GHRP

[Internal Link: /mk-677/] [Internal Link: /ghrp-6/]

Lab Work and Monitoring

Baseline Labs (Before Starting)

• IGF-1 (primary marker of GH status)
• Fasting glucose and HbA1c
• Fasting insulin
• Complete metabolic panel
• Lipid panel

Follow-Up Labs (8-12 Weeks)

• IGF-1 (expect 20-40% increase)
• Fasting glucose (ensure no significant elevation)
• Repeat metabolic panel

Canadian Lab Access

In most Canadian provinces, IGF-1 testing can be requested through a naturopath or ordered through private labs (LifeLabs, Dynacare) without physician referral. Cost: approximately $50-80 CAD for IGF-1 alone.

Frequently Asked Questions

Can I mix CJC-1295 and Ipamorelin in the same syringe?

Yes. This is standard practice. Draw CJC-1295 first, then Ipamorelin into the same insulin syringe. Both peptides are stable together in solution for immediate injection. Do not pre-mix vials for storage — combine only at time of use.

How long until I see fat loss from CJC-1295 + Ipamorelin?

Measurable fat loss typically begins at weeks 4-6, assuming caloric deficit or maintenance intake with consistent training. By week 8-12, most researchers report noticeable body composition changes. This is not a rapid fat loss intervention — it's a metabolic optimization that compounds over time.

Will this stack show up on drug tests?

CJC-1295 and Ipamorelin are detectable on WADA (World Anti-Doping Agency) testing panels. Both are prohibited in competition and out-of-competition under the S2 category (Peptide Hormones, Growth Factors). Canadian athletes subject to CCES testing should be aware this stack is banned.

Can I use CJC-1295 + Ipamorelin with testosterone or SARMs?

Yes. GH peptides are frequently stacked with testosterone replacement or anabolic compounds. GH synergizes with androgens for body composition — the androgens drive protein synthesis while GH mobilizes fat and supports recovery. No contraindication exists for concurrent use.

Do I need to cycle CJC-1295 + Ipamorelin?

Standard recommendation: 8-12 weeks on, 4 weeks off. The "off" period allows assessment of maintained benefits and prevents theoretical (but unproven) pituitary desensitization. Some researchers run indefinitely at standard doses without reported issues, but cycling is considered best practice.

Conclusion

The CJC-1295 + Ipamorelin combination is the gold standard growth hormone stack for a reason: it's effective, selective, well-tolerated, and replicable. By combining GHRH signaling with ghrelin receptor amplification, it produces GH pulses comparable to pharmacological HGH — through your own pituitary, maintaining natural feedback loops, at a fraction of the cost.

For Canadian researchers pursuing fat loss, anti-aging, or enhanced recovery, this stack represents the highest-yield, lowest-risk entry point into GH optimization. Start with the standard 100mcg + 100mcg protocol, time your doses around meals and sleep, and assess at 8 weeks with lab work.

The benefits compound. The side effects are manageable. And unlike exogenous HGH, you're not replacing a system — you're restoring one.

[Internal Link: /cjc-1295-no-dac/] [Internal Link: /ipamorelin/] [Internal Link: /peptide-stacks/]

---

References

[1] Teichman SL, et al. "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults." Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799-805.

[2] Raun K, et al. "Ipamorelin, the first selective growth hormone secretagogue." European Journal of Endocrinology. 1998;139(5):552-561.

[3] Jimenez-Reina L, et al. "Ipamorelin does not release cortisol, prolactin, or ACTH." Growth Hormone & IGF Research. 1999;9(5):290.

[4] Bowers CY, et al. "Synergistic release of growth hormone by GHRP and GHRH." Journal of Clinical Endocrinology & Metabolism. 1984;59(4):764-768.

[5] Bowers CY. "Growth hormone-releasing peptide (GHRP)." Cellular and Molecular Life Sciences. 1998;54(12):1316-1329.

[6] Veldhuis JD, et al. "Motivations and methods for analyzing pulsatile hormone secretion." Endocrine Reviews. 2008;29(7):823-864.

[7] Van Cauter E, et al. "Interrelationships between growth hormone and sleep." Growth Hormone & IGF Research. 2000;10(Suppl B):S57-S62.

[8] Lanzi R, et al. "Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects." Metabolism. 1999;48(9):1152-1156.

[9] Anderson LL, et al. "Growth hormone secretagogue receptor (GHS-R1a) saturation kinetics in vivo." Endocrinology. 2001;142(1):163-168.

[10] Frieboes RM, et al. "Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man." Neuroendocrinology. 1995;61(5):584-589.

[11] Nam SY, et al. "Effect of growth hormone on visceral fat accumulation." Obesity Research. 2001;9(Suppl 4):S188-S195.

[12] Ionescu M, et al. "Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295." Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4792-4797.

[13] Iranmanesh A, et al. "Age and relative adiposity are specific negative determinants of the frequency and amplitude of GH secretory bursts." Journal of Clinical Endocrinology & Metabolism. 1991;73(5):1081-1088.

[14] Arvat E, et al. "Preliminary evidence for an effect of hexarelin on cortisol secretion in man." Journal of Endocrinological Investigation. 1994;17(2):135-138.